Arborbridge wrote:dealtn wrote:UncleEbeneezer wrote:
Isn't that an accidental (not tested as such) observation, and therefore no better than anecdotal?
No it was accidentally done, not accidentally observed, and was as tested as other variants. It was unintentional, not anecdotal.
A happy accident. I believe there have been many in the history of science.
As someone has already quoted further up the thread, it seems that more recent data / more sub-analysis of the data is starting to suggest the better efficacy seemingly observed in the LD/SD perhaps wasn't due to the LD/SD regimen, rather that it was potentially due to this LD/SD group being the group that had the longest (average) period between first dose and second dose.
https://www.theguardian.com/world/2021/ ... in-england
"Evidence now suggests that spacing out doses of the AstraZeneca/Oxford vaccine may be more effective at protecting people. Clinical trials revealed the efficacy of the vaccine was substantially higher, at 90%, in a subgroup of people who received half a dose followed by a full dose, rather than two full doses, which had an efficacy of 62%.
But Prof Wei Shen Lim, the chair of the Covid-19 immunisation group of the JCVI, told MPs further analysis by AstraZeneca showed the improved protection came from spacing out the doses.
“People who had the half dose then full dose were those who were vaccinated at a longer time interval, roughly six to 12 weeks, and what they’ve seen in their data is that people who have the second dose later probably have a three times higher antibody level than those who were vaccinated earlier. So if anything, it suggests that increasing the dose interval is beneficial,” he said.
Sir Mene Pangalos, the executive vice-president of biopharmaceuticals research and development at AstraZeneca, told the committee the first vaccine shot was more protective over time."